David Margolis, MD
Enriched profileSarah Graham Kenan Distinguished Professor of Medicine, Microbiology & Immunology, and Epidemiology; Director of the UNC HIV Cure Center · University of North Carolina at Chapel Hill
David Margolis is Sarah Graham Kenan Distinguished Professor of Medicine, Microbiology & Immunology, and Epidemiology; Director of the UNC HIV Cure Center at University of North Carolina at Chapel Hill. OpenAlex indexes 529 publications with 29,636 citations (h-index 88); ClinicalTrials.gov lists 12 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
David Margolis, MD, is Sarah Graham Kenan Distinguished Professor of Medicine, Microbiology & Immunology, and Epidemiology at University of North Carolina at Chapel Hill. The public record shows 529 publications with 29,636 citations (h-index 88), centered on HIV Research and Treatment, HIV/AIDS drug development and treatment, Virus-based gene therapy research. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 4 companies, 18 NIH-funded awards (2005–2026).
- Most recent indexed publication: 2026 · Science advances
- Top research focus: HIV Research and Treatment
- 12 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 30 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 279.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:
- Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients
Sponsor: University of North Carolina, Chapel Hill
- Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons
Sponsor: University of North Carolina, Chapel Hill
- Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)
Sponsor: University of North Carolina, Chapel Hill
Industry payments
Updated 18 Oct 2026
4 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202513 payments$12,647openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year20232 payments
- ViiV Healthcare CompanyProgram year20221 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
40.5%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor30.2%Dovato67%Tivicay14%Juluca11%Cabenuva7%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor6.3%Descovy73%Triumeq27%Part D<11 patients+ 2 more classes in this area
Cardiovascular
19.4%Statin12.5%Pravastatin Sodium46%Atorvastatin Calcium31%Rosuvastatin Calcium24%Part D<11 patientsCalcium channel blocker5.1%Amlodipine Besylate100%Part D<11 patients+ 1 more class in this area
Nervous system
16.5%SSRI4.6%Citalopram Hbr53%Trazodone Hcl47%Part D<11 patientsNonsteroidal Anti-inflammatory Drug4%Ibuprofen50%Meloxicam50%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
18 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- Collaboratory of AIDS Researchers for Eradication (CARE)
Univ of North Carolina Chapel Hill
FY2026$5,318,544UM1AI164567 - The University of North Carolina Center for AIDS Research
Univ of North Carolina Chapel Hill
FY2026$3,155,764P30AI050410 - UNC Center for AIDS Research Core A Administration
Univ of North Carolina Chapel Hill
FY2026$861,811P30AI050410
Congress activity
Updated 18 Oct 2026
3 congress contributions (2018–2021) across ASH per OpenAlex. The most recent:
- Real World Survival Outcomes of CPX-351 Versus Venetoclax and Azacitadine for Initial Therapy in Adult Acute Myeloid Leukemia
ASH Annual Meeting
ASH2021Co-author - Related and Unrelated Donor Transplantation for β Thalassemia Major: Results of an International Survey
ASH Annual Meeting
ASH2018Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Correction for Raines et al., "Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets".
Antimicrobial agents and chemotherapy
Erratum2025 - Dolutegravir/Abacavir/Lamivudine in Acute HIV-1 Results in Rapid Suppression and Restoration of CD4 T-cell Subsets Without Accelerated Decay of Latent HIV-1.
Open forum infectious diseases
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory TractArticle1,488 citations2020
- 02Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapyArticle1,141 citations2012
- 03Cabotegravir for HIV Prevention in Cisgender Men and Transgender WomenArticle902 citations2021
- 04SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivoArticle900 citations2020
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
unclineberger.org/directory/david-margolis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗ - Other
med.unc.edu/cfar/people/david-margolis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗
- MD
Tufts University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Editorial & leadership roles
journal and society appointments- Member
Editorial Board, Journal of Infectious Diseases
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Member
Editorial Board, Retrovirology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Awards & honors
honors on the public record- Fellow
American Association for the Advancement of Science
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗
- Member
American Society of Clinical Investigation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗ - Member
Association of American Physicians
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗ - Fellow
Infectious Diseases Society of America
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗ - Fellow
American College of Physicians
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗
Secondary affiliations
appointments beyond the home institution- Co-Director
UNC Center for AIDS Research (CFAR)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗ - Principal Investigator
CARE (Collaboratory of AIDS Researchers for Eradication)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Douglas Drossman, MD
University of North Carolina at Chapel Hill
Michael Knowles, MD
University of North Carolina at Chapel Hill
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital